Prevalence of Polycystic Ovarian Syndrome in Girls with a History of Idiopathic Central Precocious Puberty
Hormone Research in Paediatrics · 2024 · 97 (2) · 134-139
DOI: 10.1159/000531264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 08.08.2023. Verfasst von Andrea Josefina Arcari und 7 weiteren Autor:innen. Beteiligte Einrichtung: División de Endocrinología, Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET, FEI, Hospital de Niños Ricardo Gutiérrez,…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Puberty, Precocious, Hyperandrogenism. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Introduction
The prevalence of polycystic ovarian syndrome (PCOS) in adolescent girls is between 1 and 4.3%. It remains controversial whether women with a history of idiopathic central precocious puberty (ICPP) are at increased risk for PCOS. Our objective was to assess the prevalence of PCOS in adolescents with a history of ICPP compared with healthy adolescents and the prevalence of PCOS among ICPP girls who have received or not gonadotropin-releasing hormone analogue (GnRHa) treatment.
Methods
We assessed post-menarcheal girls with a history of ICPP. Girls were evaluated at gynecological age ≥2.5 years. Data collected were age at menarche, menstrual cycle characteristics, BMI, clinical hyperandrogenism (HA), total and free testosterone levels. PCOS diagnosis was defined by criteria for adolescents. Subjects were also analyzed regarding whether or not they had received GnRHa treatment.
Results
Ninety-four subjects were assessed, and 63 had been treated with GnRHa. Menstrual disorders were found in 29%, clinical HA in 36%, and biochemical HA in 23%. Twelve percent met the diagnostic criteria for PCOS. There was no difference in BMI or in the incidence of menstrual dysfunction or hyperandrogenemia between treated and untreated patients. A higher proportion of clinical HA was found in untreated patients when compared to treated girls. The relative risk (RR) of developing PCOS in ICPP girls was 2.5 compared to a population of healthy adolescents. This RR was not higher in patients who received treatment with GnRHa than in those who did not.
Conclusion
Adolescent girls with a history of ICPP have an increased risk of PCOS. This risk seems not to be related to GnRHa treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- División de Endocrinología, Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CEDIE) CONICET, FEI, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.
Zitieren
APA
Arcari, A. J., Freire, A. V., Ballerini, M. G., Escobar, M. E., Díaz Marsiglia, Y. M., Bergadá, I., Ropelato, M. G., & Gryngarten, M. G. (2024). Prevalence of Polycystic Ovarian Syndrome in Girls with a History of Idiopathic Central Precocious Puberty. Hormone Research in Paediatrics, 97(2), 134-139. https://doi.org/10.1159/000531264
Vancouver
Arcari AJ, Freire AV, Ballerini MG, Escobar ME, Díaz Marsiglia YM, Bergadá I, et al. Prevalence of Polycystic Ovarian Syndrome in Girls with a History of Idiopathic Central Precocious Puberty. Hormone Research in Paediatrics. 2024;97(2):134-139. doi:10.1159/000531264
BibTeX
@article{Arcari2024,
author = {Arcari, Andrea Josefina and Freire, Analía Verónica and Ballerini, María Gabriela and Escobar, María Eugenia and Díaz Marsiglia, Yenifer María and Bergadá, Ignacio and Ropelato, María Gabriela and Gryngarten, Mirta Graciela},
title = {Prevalence of Polycystic Ovarian Syndrome in Girls with a History of Idiopathic Central Precocious Puberty},
journal = {Hormone Research in Paediatrics},
year = {2024},
volume = {97},
number = {2},
pages = {134--139},
doi = {10.1159/000531264}
}
EUVIMED